Management of pituitary apoplexy: clinical experience with 40 patients
- PMID: 15570437
- DOI: 10.1007/s00701-004-0413-2
Management of pituitary apoplexy: clinical experience with 40 patients
Abstract
Background: Pituitary apoplexy is a rare major clinical event with neurological, neuro-ophthalmological, cardiovascular and hormonal consequences, resulting from an acute infarction of pituitary adenoma. We report our experience with a series of 40 patients presenting with pituitary apoplexy.
Patients: Forty patients (27 males, 13 females; mean age, 51.2 yr) were admitted to our medical center between years 1985-2002 with acute presentation of pituitary apoplexy. Visual field defects occurred in 61% and ocular paresis in 40% of subjects. Sixty-three percent of adenomas were nonfunctional, and prolactinomas comprised 31%.
Results: Thirty-four patients underwent transsphenoidal pituitary decompression. Visual fields and ophthalmoplegia improved in 81% and 71%, respectively. During follow-up (4.5+/-5.4 yr), 79% of patients developed hypogonadotrophic hypogonadism, central hypothyroidism appeared in 54% and hypocortisolism--in 40% of patients. Permanent diabetes insipidus was diagnosed in 8%. Serial sellar MRI showed disappearance of pituitary tumor in 63% of operated subjects. Six patients (3 with PRL-secreting and 3 nonfunctional adenomas) were treated medically (corticosteroids, dopamine agonists), two patients (out of three) with visual deficits improved, and tumor shrinkage was noted in four.
Conclusions: We present a large series of patients with pituitary apoplexy. Most subjects were operated, but six were treated conservatively. Almost all patients improved clinically, including those who were not operated, but hormonal deficiencies are very common.
Similar articles
-
Visual outcome of blind eyes in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes.Surg Neurol. 2005 Jan;63(1):42-6; discussion 46. doi: 10.1016/j.surneu.2004.03.014. Surg Neurol. 2005. PMID: 15639521
-
Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome.J Clin Neurosci. 2008 Aug;15(8):873-9. doi: 10.1016/j.jocn.2007.08.010. Epub 2008 May 27. J Clin Neurosci. 2008. PMID: 18502643
-
Tuberculum sellae meningiomas: functional outcome in a consecutive series treated microsurgically.Surg Neurol. 2006 Jul;66(1):37-44; discussion 44-5. doi: 10.1016/j.surneu.2005.11.059. Surg Neurol. 2006. PMID: 16793435
-
Pituitary apoplexy: an overview of 186 cases published during the last century.Acta Neurochir (Wien). 2010 May;152(5):749-61. doi: 10.1007/s00701-009-0595-8. Epub 2010 Feb 6. Acta Neurochir (Wien). 2010. PMID: 20140630 Review.
-
Pituitary apoplexy: evaluation, management, and prognosis.Curr Opin Ophthalmol. 2009 Nov;20(6):456-61. doi: 10.1097/ICU.0b013e3283319061. Curr Opin Ophthalmol. 2009. PMID: 19809320 Review.
Cited by
-
Pituitary apoplexy score, toward standardized decision-making: a descriptive study.Pituitary. 2024 Feb;27(1):77-87. doi: 10.1007/s11102-023-01372-x. Epub 2023 Dec 27. Pituitary. 2024. PMID: 38150169
-
Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.Pituitary. 2018 Apr;21(2):111-118. doi: 10.1007/s11102-018-0869-3. Pituitary. 2018. PMID: 29368293 Review.
-
Endoscopic Endonasal Transsphenoidal Treatment of Pituitary Apoplexy: Outcomes in a Series of 20 Patients.Cureus. 2015 Oct 20;7(10):e357. doi: 10.7759/cureus.357. Cureus. 2015. PMID: 26623212 Free PMC article.
-
Pituitary apoplexy.Indian J Endocrinol Metab. 2011 Sep;15 Suppl 3(Suppl3):S188-96. doi: 10.4103/2230-8210.84862. Indian J Endocrinol Metab. 2011. PMID: 22029023 Free PMC article.
-
The Pituitary Gland: An Infrequent but Multifaceted Contributor to Death.Acad Forensic Pathol. 2016 Jun;6(2):206-216. doi: 10.23907/2016.023. Epub 2016 Jun 1. Acad Forensic Pathol. 2016. PMID: 31239893 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical